Ken Griffin Asensus Surgical, Inc. Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.23 - $0.35 $6,241 - $9,497	-27,137 Reduced 50.97%	26,106 $6,000
Q4 2023 Feb 14, 2024	BUY	$0.21 - $0.36 $11,181 - $19,167	53,243 New	53,243 $17,000
Q2 2023 Aug 14, 2023	BUY	$0.46 - $0.81 $21,357 - $37,608	46,430 New	46,430 $23,000
Q4 2022 Feb 14, 2023	BUY	$0.29 - $0.47 $12,826 - $20,788	44,231 New	44,231 $15,000

40.1M

12.4K

Ticker ASXC
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 236,719,008
Market Cap $82.9M
Description
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.